Gustavo M. Cervantes

CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases

Ravi Salgia, Rifat Hasina, Kenan Onel, 2010, PloS one.

MET/PKCß expression correlate with metastasis and inhibition is synergistic in lung cancer

M. Westerhoff, R. Salgia, E. Vokes, 2009, Journal of carcinogenesis.

Differential expression of RON in small and non–small cell lung cancers

R. Salgia, E. Vokes, M. Tretiakova, 2012, Genes, chromosomes & cancer.

MET receptor tyrosine kinase.

R. Salgia, L. Faoro, Essam El-Hashani, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma

Y. Bang, R. Salgia, E. Vokes, 2011, Cancer biology & therapy.

EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation*

R. Salgia, Frances E. Lennon, E. Vokes, 2010, The Journal of Biological Chemistry.

Cytokeratin-based CTC counting unrelated to clinical follow up.

F. Soares, P. Paterlini-Bréchot, Gustavo M. Cervantes, 2013, Journal of thoracic disease.

The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target

A. Iafrate, R. Salgia, E. Vokes, 2013, PloS one.

Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells

H. Al-Ahmadie, R. Salgia, E. Posadas, 2011, Clinical Cancer Research.

Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism

R. Salgia, E. Vokes, M. Tretiakova, 2011, Journal of carcinogenesis.